Back

Ischaemic Conditioning in High-Risk ST-elevation Myocardial Infarction: The Randomized, Multicentre, RIP-HIGH Trial

29 August 2026 (18:15 - 18:30)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes: new strategies for diagnosis, risk stratification and early treatment Reperfusion and Reperfusion Injury ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Hans-Josef Feistritzer

Heart Center Leipzig at University of Leipzig, Leipzig (Germany)

3 More presentations in this session

Presentation thumbnail
Modified HEART Score Triage With Point-of-Care hs-cTnI in Suspected ACS: Clinical Outcomes in the HARTc 2.0 Randomized Trial
Ms A. van der Lande (Leiden, NL)
Slides Video
Presentation thumbnail
The Long-cTnT/hs-cTnT Ratio as a Novel Discriminator Between Takotsubo Syndrome and Acute Coronary Syndrome
Doctor Y. Wang (Zurich, CH)
Slides Video
Presentation thumbnail
A Clinical Decision Rule with High-Sensitivity Troponin to Rule Out Acute Coronary Syndrome in Primary Care (POB HELP): A Diagnostic Trial
Assistant Professor T. Bonten (Leiden, NL)
Slides Video

Access the full session

Session thumbnail
Acute coronary syndromes: new strategies for diagnosis, risk stratification and early treatment
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 18:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardioprotection by combined intrahospital remote ischaemic perconditioning and intracoronary postconditioning in ST-elevation myocardial infarction: the randomized CARIOCA trial
20 March 2026
thumbnail
Congress Presentation
Protective effects of remote ischemic preconditioning in patients undergoing isolated valve replacement surgery: a meta-analysis
29 August 2025
thumbnail
Congress Session
Cardiovascular trends: hospitalisations, trials, and genetic therapies
2 September 2024
thumbnail
Congress Presentation
Immediate Versus Deferred Percutaneous Coronary Intervention in Clinically Stable Patients with STEMI Presenting Beyond 12 Hours of Symptom Onset - The LATE-MI Randomized Trial
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources